Interactive effect of the serotonin transporter (5-HTTLPR) genotype and life stress predicting bipolar symptomatology

作者: Amelia Kotte

DOI:

关键词:

摘要: In patients with bipolar disorder, the serotonin transporter gene polymorphism (5-HTTLPR) is associated effectiveness of lithium prophylaxis and affective instability in response to environmental stress. This cross-sectional study investigated whether symptomatology at baseline for a treatment consistent diathesis-stress model. Forty -two participants disorder completed battery measures assessing demographic information, life stress, symptoms disorder. Participants underwent phlebotomy procedures genotyping. MANOVA tests showed significant main effect event severity (Wilk's [Lambda] = .714, F [4,31] 2.20, p =.029). presence severe scored significantly higher depressive were deemed more ill by clinicians. There was omnibus 3-way interaction between events, 5- HTTLPR, status .367, [4, 33] 3.020, =.031). A trend toward significance 5-HTTLPR found; i.e., lower depression scores present s/s s/l taking lithium, as opposed l/l participants, when events but not absent. loss predicting manic (F[1,38] 4.15, .04). reported than those without. an baseline: ([mu] 1.70) 9). goal-attainment 5.95, .01). least one Findings partially No found genotype symptomatology. The results suggest effective buffering against s allele experience events. Results increase understanding environment mechanisms, imply improvement identification risk poor prognosis help direct therapeutic techniques

参考文章(177)
Martha X Sajatovic, Frederic C. Blow, Frederic C. Blow, Rosalinda V. Ignacio, Kristin A. Cassidy, Tiffany D. Williams, Kavi K. Devulapalli, Roknedin Safavi, Peter Weiden, Why do persons with bipolar disorder stop their medication Psychopharmacology Bulletin. ,vol. 43, pp. 5- 14 ,(2010)
E. H. Uhlenhuth, Shelby J. Haberman, Michael D. Balter, Ronald S. Lipman, Remembering Life Events Springer, Boston, MA. pp. 117- 134 ,(1977) , 10.1007/978-1-4684-2355-6_7
Kate E Hamilton, Keith S Dobson, Cognitive therapy of depression: pretreatment patient predictors of outcome. Clinical Psychology Review. ,vol. 22, pp. 875- 893 ,(2002) , 10.1016/S0272-7358(02)00106-X
Lauren B. Alloy, Noreen Reilly-Harrington, David M. Fresco, Wayne G. Whitehouse, Jeanne S. Zechmeister, Cognitive styles and life events in subsyndromal unipolar and bipolar disorders: Stability and prospective prediction of depressive and hypomanic mood swings. Journal of Cognitive Psychotherapy. ,vol. 13, pp. 21- 40 ,(1999) , 10.1891/0889-8391.13.1.21
A M Shoaib, T C Bowers, A C Swann, S C Dilsaver, The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate. Journal of Psychiatry & Neuroscience. ,vol. 18, pp. 61- 66 ,(1993)
B??rbara Arias, Rosa Catal??n, Crist??bal Gast??, Blanca Guti??rrez, Lourdes Fa??an??s, 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. Journal of Clinical Psychopharmacology. ,vol. 23, pp. 563- 567 ,(2003) , 10.1097/01.JCP.0000095350.32154.73
Alessandro Serretti, Paola Artioli, Predicting response to lithium in mood disorders: role of genetic polymorphisms. American Journal of Pharmacogenomics. ,vol. 3, pp. 17- 30 ,(2003) , 10.2165/00129785-200303010-00004
Rif S. El-Mallakh, Lithium : actions and mechanisms ,(1996)
John H. Greist, James W. Jefferson, Primer of lithium therapy Williams and Wilkins. ,(1977)
M Berk, J Segal, S Brook, Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacology. ,vol. 21, pp. 176- 180 ,(1998)